Qelbree (viloxazine) is a prescription drug that’s used to treat attention deficit hyperactivity disorder (ADHD). Qelbree comes as an oral capsule. Qelbree is prescribed for use in adults and certain ...

Supernus Pharmaceuticals has two key selling points for its newly minted Qelbree: It's the first non-stimulant ADHD drug to win approval in a decade, and it appears to start working more quickly than ...

Credit: Supernus Qelbree is a selective norepinephrine reuptake inhibitor. Qelbree™ (viloxazine extended-release capsules), is now available for the treatment of attention-deficit hyperactivity ...

The approval was based on data from an extensive development program that included four phase 3 studies involving more than 1000 patients 6 to 17 years of age with ADHD. The Food and Drug ...